Sartorius Stedim Biotech バランスシートの健全性
財務の健全性 基準チェック /26
Sartorius Stedim Biotechの総株主資本は€3.9B 、総負債は€2.7Bで、負債比率は68.4%となります。総資産と総負債はそれぞれ€8.0Bと€4.1Bです。 Sartorius Stedim Biotechの EBIT は€398.9Mで、利息カバレッジ比率1.8です。現金および短期投資は€482.6Mです。
主要情報
68.4%
負債資本比率
€2.69b
負債
| インタレスト・カバレッジ・レシオ | 1.8x |
| 現金 | €482.60m |
| エクイティ | €3.94b |
| 負債合計 | €4.06b |
| 総資産 | €8.00b |
財務の健全性に関する最新情報
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 11
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Recent updates
Sartorius Stedim Biotech's (EPA:DIM) Weak Earnings May Only Reveal A Part Of The Whole Picture
Oct 25Sartorius Stedim Biotech S.A.'s (EPA:DIM) Share Price Not Quite Adding Up
Oct 15Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 11Sartorius Stedim Biotech S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Jul 21Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Jul 12Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet
May 13Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24財務状況分析
短期負債: DIMの 短期資産 ( €1.6B ) が 短期負債 ( €757.9M ) を超えています。
長期負債: DIMの短期資産 ( €1.6B ) は 長期負債 ( €3.3B ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: DIMの 純負債対資本比率 ( 56.1% ) は 高い と見なされます。
負債の削減: DIMの負債対資本比率は、過去 5 年間で7.6%から68.4%に増加しました。
債務返済能力: DIMの負債は 営業キャッシュフロー によって 十分にカバー されています ( 32.2% )。
インタレストカバレッジ: DIMの負債に対する 利息支払い は EBIT ( 1.8 x coverage) によって 十分にカバーされていません。